GORTEC: Cisplatin chemoradiation plus debio 1143 in patients with locally advanc...
Prof Jean Bourhis - Lausanne University Hospital, Lausanne, Switzerland
14 Oct 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
24 Jun 2019
Comment: Chemotherapy for frail and elderly patients with advanced gastroesophag...
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
13 Jun 2019
Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers...
Prof Bob Li - Memorial Sloan Kettering Cancer Center, New York City, USA
11 Jun 2019
Principle and technique for radiofrequency ablation of benign thyroid nodules
Prof Kwang Hwi Lee - Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United A...
8 May 2019
Perception of tobacco use in young adults of urban India
Ms Soumita Ghose - Tata Medical Centre, Kolkata, India
28 Mar 2019
Updates in head and neck cancers
Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium
22 Oct 2018
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell ca...
Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer Cente...
22 Oct 2018
Cisplatin superior to cetuximab for HPV oropharyngeal cancer
Prof Hisham Mehanna - University of Birmingham , Birmingham, UK
22 Oct 2018
Cisplatin v cetuximab for HPV associated oropharyngeal cancer
Prof Hisham Mehanna - University of Birmingham , Birmingham, UK
22 Oct 2018
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck s...
Prof Barbara Burtness - Yale Cancer Center, New Haven, USA
22 Oct 2018
ESMO 2018: Highlights
Prof Gordon McVie , Will Davies
22 Oct 2018
